TARDBP and amyotrophic lateral sclerosis: Finally, as an attempt to assess the therapeutic potential of MEKi in treating TDP-43-assoicated ALS, we examined the effectiveness of an FDA-approved MEKi trametinib using the elavGS > hTDP-43 flies (Fig. 4a).